Entity family

Browse drugs

Named medicines, compounds, vaccines, and pharmacological agents. Examples include metformin, semaglutide, antibiotics.

5articles mentioning drugs

10drug mentions

1distinct drugs extracted

0%of mentions human-reviewed

Active filtersEntity: linagliptin ×

linagliptin

This drug is selected. Its supporting articles are shown below.

linagliptin5

Articles mentioning linagliptin

5 articles · page 1 of 1

Enhancing evidence-based care using trial emulation in electronic health records: real-world effects of empagliflozin in people with type 2 diabetes

bmjdrc · full text · 2026-02-09 · 4 matching annotations

95.0%

…ple with T2DM and established CVD to receive either the SGLT2i, empagliflozin, or placebo.5 To be eligible for this study, people had to meet…

Evaluating the effects of liraglutide, empagliflozin and linagliptin on mild cognitive impairment remission in patients with type 2 diabetes (LIGHT-MCI): study protocol for a multicentre, randomised controlled trial with an extension phase

bmjopen · abstract · 2025-08-21 · 3 matching annotations

98.4%

linagliptin liraglutide empagliflozin Diabetes Drum Tower Hospital Affiliated to Nanjing University Medical School cognitive dysfunction

…ndomly allocated 1:1:1 to receive liraglutide, empagliflozin or linagliptin treatment. The primary outcome measure is the efficacy differen…

FP25 Efficacy of SGLT2 inhibitors versus DPP4 inhibitors in metabolic dysfunction-associated steatotic liver disease (MASLD): a multicenter propensity-matched real-world study

gutjnl · abstract · 2026-06-23 · 1 matching annotations

95.3%

DPP4is sitagliptin linagliptin canagliflozin empagliflozin dapagliflozin Ascites SGLT2is TriNetX U.S. Collaborative Network

…=111,357; e.g., empagliflozin, dapagliflozin, canagliflozin) or DPP4is (n=43,868; e.g., sitagliptin, linagliptin) without cross-exposu…

Association of GLP-1 receptor agonists with intentional self-harm in patients with type 2 diabetes: a Sentinel Distributed Database study

bmjdrc · full text · 2026-03-18 · 1 matching annotations

85.2%

DPP-4is GLP-1 RAs GLP-1 RA SGLT-2is DPP-4i

…CI −0.53 to 0.86 events per 1000 person-years) or compared with DPP-4is (HR 0.94; 95% CI 0.71 to 1.24, rate difference −0.18; 95% CI −0…

10-Minute Consultation: Osteopenia

bmj · abstract · 2025-10-22 · 1 matching annotations

99.1%

atorvastatin metformin linagliptin osteoporosis type 2 diabetes hyperlipidaemia

…etes and hyperlipidaemia, and takes metformin, linagliptin, and atorvastatin. She does not smoke or drink alcohol. She reports reaching meno…